Genome Biologics
Hessen
About Genome Biologics
Genome Biologics are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses where no other treatments have proven effective or ever existed.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.2M
- Last round: Series Unknown (Oct 2021)
- Website: genomebiologics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/genome-biologics-18172 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.